Log In
Print
BCIQ
Print
Print this Print this
 

Sebivo, Tyzeka, telbivudine (LdT) (LDT600)

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionNucleoside analog
Molecular Target Viral polymerase
Mechanism of ActionDNA polymerase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHepatitis B virus (HBV)
Indication DetailsTreat chronic hepatitis B virus (HBV) infection
Regulatory Designation

Partner

Novartis AG


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today